Versant Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$59.4K Buy
1,465
+20
+1% +$973 0.01% 1289
2026
Q2
$75.7K Buy
1,445
+366
+34% +$14.3K 0.01% 1084
2026
Q1
$38.2K Sell
1,079
-99
-8% -$3.07K ﹤0.01% 1398
2025
Q4
$33K Sell
1,178
-84
-7% -$2.52K ﹤0.01% 1327
2025
Q3
$37.9K Buy
1,262
+73
+6% +$2.06K 0.01% 1189
2025
Q2
$34K Buy
1,189
+343
+41% +$10.2K 0.01% 1206
2025
Q1
$27.9K Buy
846
+130
+18% +$4.24K ﹤0.01% 1146
2024
Q4
$20.6K Buy
716
+495
+224% +$14.2K ﹤0.01% 1022
2024
Q3
$6.19K Buy
221
+72
+48% +$1.92K ﹤0.01% 1221
2024
Q2
$3.59K Buy
149
+116
+352% +$2.84K ﹤0.01% 1331
2024
Q1
$893 Hold
33
– – ﹤0.01% 1568
2023
Q4
$915 Buy
33
+23
+230% +$597 ﹤0.01% 1539
2023
Q3
$280 Sell
10
-41
-80% -$1.2K ﹤0.01% 1803
2023
Q2
$1.6K Buy
51
+41
+410% +$1.24K ﹤0.01% 1452
2023
Q1
$278 Buy
+10
New +$272 ﹤0.01% 1673
2021
Q1
– Sell
-15
Closed – – 1506
2020
Q4
$0 Buy
+15
New +$275 ﹤0.01% 1323

Other funds holding ALKS

Versant Capital Management's ALKS Position: Q3 2026 in Review

Versant Capital Management increased its Alkermes (ALKS) stake by 1.4% in Q3 2026, buying an estimated $973 and bringing the position to 1,465 shares worth $59.4K. The position accounts for 0.01% of the portfolio, ranked #1289.

Versant Capital Management first reported a position in ALKS in Q4 2020 and has held it in 16 quarters since. The position peaked at $75.7K in Q2 2026. 401 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Versant Capital Management held 1,465 shares of Alkermes worth $59.4K as of Q3 2026.
  • Versant Capital Management bought 20 Alkermes shares in Q3 2026, an estimated $973.
  • Alkermes made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #1289 holding.
  • Versant Capital Management first reported a position in Alkermes in Q4 2020 and has held it in 16 quarters since.
  • Versant Capital Management's Alkermes position peaked at $75.7K in Q2 2026.
  • 401 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.